Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target "multiple immune cell types (analogous to rabbit ATG)" refers collectively to a range of surface-expressed proteins found on diverse leukocyte populations—including T-cells (CD2/CD3/CD4/CD8), B-cells, NK-cells, macrophages/dendritic cells—as well as MHC molecules. These are recognized by polyclonal rabbit-derived IgGs generated against human thymocytes or T-cell lines. This multi-target approach underlies the potent immunosuppressive effects observed with rabbit ATGs in clinical practice.
Depletion of targeted lymphocyte populations via complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. Modulation or downregulation of antigen expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Immune Cell Types (Analogous to Rabbit ATG) (N/A).